Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to...
State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed Forces PacificArmed...
GIFT Nifty: GIFT Nifty September 2025 futures were trading with a gain of 58.50 points (or 0.23%) in...
SINGAPORE, Sept. 9, 2025 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), today announced it will...
In the fast-paced world of fintech, few stories capture the imagination quite like that of Ramp, the New York-based startup...
- Check against delivery – Statement Walter Mertl Member of the Board of Management of BMW AG, Finance Annual...
Please create an employee account to be able to mark statistics as favorites. Then you can access your favorite statistics...
An Amerikan Family: The Shakurs and the Nation They CreatedSanti Elijah HolleyBiography and memoir Chasing Hope: A Reporter’s LifeNicholas D....